We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest whitepaper , Mark Wade, Global Practice Leader for TransPerfect Life Sciences examines the considerations of adopting these sensors as an addition to the typical Clinical Outcome Assessment (COA) tools used routinely today.

What are the impacts on a study team? What are the considerations in selecting these modalities? Consumer grade vs. industrial grade? Download the whitepaper now to learn about the use of wearables as eCOA tools.

Written by: Mark Wade, Global Practice Leader, TransPerfect Life Sciences